RAS (KRAS OR NRAS) GENE MUTATION
Clinical trials for RAS (KRAS OR NRAS) GENE MUTATION explained in plain language.
Never miss a new study
Get alerted when new RAS (KRAS OR NRAS) GENE MUTATION trials appear
Sign up with your email to follow new studies for RAS (KRAS OR NRAS) GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early-phase study tests an experimental oral drug called NST-628 in adults with advanced solid tumors that have specific genetic changes in the MAPK pathway. The main goals are to check the drug's safety, find the right dose, and see if it can shrink tumors. About 230 partic…
Matched conditions: RAS (KRAS OR NRAS) GENE MUTATION
Phase: PHASE1 • Sponsor: Nested Therapeutics, Inc • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Huge canadian study tracks rare cancer mutations to improve treatment
Knowledge-focused Recruiting nowThis study is collecting information from 5,500 Canadian cancer patients whose tumors have rare genetic changes. Researchers want to see how well current targeted drugs work for these uncommon mutations. Participants are observed over time, and their treatment outcomes, side effe…
Matched conditions: RAS (KRAS OR NRAS) GENE MUTATION
Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC